KARAMBIOSCIENCE
EST. 2026
EVIDENCE / 02
Research / 2026 library

THE SOURCE
COMES FIRST.

Read the finding in its actual setting. Every brief identifies the model, endpoint, primary source, access level, and the next unanswered question.

AI-generated cellular concept illustration
Concept illustration · not experimental data
New / CRISPR research & discovery

A new method layer for the Atlas.

The original 15-record cellular-aging collection remains intact. Explore 26 CRISPR and comparator records, including two shared sources—39 unique research and sponsor records across both collections.

A cinematic molecular-and-climate scene with a CRISPR complex, cells and a planet.

Fourteen papers. One sponsor update.

The collection includes null results, observational evidence, cell and animal experiments, a human trial reanalysis, and a clearly separated early sponsor report. It is not a comprehensive or independently replicated body of evidence.

Telomeres concept illustration
2026-09-03 · India

A human biomarker signal from India

Human randomized trial

Leukocyte telomere measurements, telomerase activity, and gene expression.

Mechanisms of Ageing and Development↗
Work with Karam

From evidence to a useful decision.

Evidence / Scope an engagement

Karam Evidence Sprint

One question. A source trail. A decision you can explain.

Scope & deliverables↗
Data / Technical qualification required

Karam Data Review

Find out what your existing data can actually support.

Scope & deliverables↗
Studies / Laboratory agreement required

Karam Study Desk

A defined experiment, a comparable lab scope and a usable handover.

Scope & deliverables↗